Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform
HQ: HU
Founded: 2015
Series A
Sector: Biotechnology
Investment Raised: EUR 20M €
Valuation Remains Undisclosed
Investors: Accel (https://www.accel.com/) Day One Capital (https://www.dayonecapital.com/) Delin Ventures (https://www.delinventures.com/) Mercia Fund Managers (https://www.mercia.co.uk/) Merck Global Health Innovation Fund (https://www.merckghifund.com/) XTX Ventures (https://www.xtxmarkets.com/ventures/)